In November 2023, the Foundation wrote to the United States Drug Enforcement Administration (DEA), asking them to increase the Lisdexamfetamine quota to help address global drug shortages. The work of the ADHD Foundation isn’t just limited to our national helpline and community support – did you know we also deliver meaningful advocacy for our community? […]
Our Submission to the DEA’s Proposed Lisdexamfetamine Quota
